1. Catalog
  2. OnDemand: May 2024 Grand Rounds - Human Adipose Ti ...
OnDemand: May 2024 Grand Rounds - Human Adipose Tissue Metabolism - What Happens with Obesity?
Create Account
Availability
On-Demand
Cost
Member: $0.00
Non-Member: $50.00
Credit Offered
1 AMA PRA Category 1 Credit
Dr. Jensen will discuss the basic fuel functions of adipose tissue and the exquisite control the body exercises over it in order to maintain health. He will also review the abnormalities that develop as a consequence of fat gain that occurs primarily in the truncal region and how this can negatively impact health. 
1. After participating in the webinar, learners will be able to describe the main regulators of adipose tissue fuel control and how this is impacted by obesity.

2. After this webinar, learners will be able to identify the main abnormality present in central obesity and how this can predispose to diseases.
Dr. Michael D. Jensen, MD
Professor of Medicine
Dr. Jensen received his M.D. from the University of Missouri – Kansas City and completed his internal residency medicine and subspecialty training in endocrinology & metabolism at Mayo Clinic, Rochester, MN. He holds the Tomas J. Watson, Jr. Professorship in Honor of Dr. Robert L. Frye at the Mayo College of Medicine and is a consultant in the Division of Endocrinology & Metabolism. Dr. Jensen is currently the Editor-in-Chief of Obesity.
The Obesity Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Activity ID 202573206
Date of Release: June 1, 2024
Date of Termination: December 31, 2026
No commercial support was received for this activity.
Michael Jensen, MD: Advisor relationship with Seattle Gummy (Supplement). Consultant relationship with Biohaven (Pharmaceuticals) and Medality Medical, Inc. (Medical Device). Researcher relationship with Novo Nordisk (Pharmaceuticals).
Monica Agarwal, MD: No Relevant Financial Relationships

Johnny Figueroa, PhD: No Relevant Financial Relationships

Leslie Golden, MD, MPH: No Relevant Financial Relationships

Valentina Ivezaj, PhD: No Relevant Financial Relationships

Aaron Kelly, PhD: No Relevant Financial Relationships

Robert Kushner, MD: Advisor Relationship with Novo Nordisk (Pharmaceuticals), WW (Medical Food and Weight Management*), and Eli Lilly (Pharmaceuticals) Consultant relationship with Altimmune (Pharmaceuticals), Pfizer Inc. (Pharmaceuticals), and Boehringer Ingelheim (Pharmaceuticals)

Magdalena Pasarica, MD, PhD: No Relevant Financial Relationships Jonathan Purnell, MD Consultation Relationship with Novo Nordisk (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), and Luciole (Pharmaceuticals)

Amanda Velazquez, MD: Advisor relationship with WW (Medical Food and Weight Management*) and Intellihealth (Weight Management*) Consultation Relationship with Novo Nordisk (Pharmaceuticals)

Denise Wilfley, PhD: No Relevant Financial Relationships
No members of the TOS CME Oversight Committee, charged with the resolution of all relevant conflicts of interest, had any relevant financial relationships while serving on the committee.
1. Michael D. Jensen, Visceral Fat: Culprit or Canary?, Endocrinology and Metabolism Clinics of North America, Volume 49, Issue 2, 2020, Pages 229-237. https://doi.org/10.1016/j.ecl.2020.02.002.
2. Jensen MD. Adipose tissue metabolism -- an aspect we should not neglect? Horm Metab Res. 2007 Oct;39(10):722-5. doi: 10.1055/s-2007-990274. PMID: 17952833.
Powered By